| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 20th, 2005 | 35 | No |
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | -3.51 | -4.57 | -187.16 | 4 | 15 | -3 | 253 | 499.453 | 16 | ↓ |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| CASP1-1-E | Caspase-1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 190 | 0.27 | Binding ≤ 10μM |
| CASP3-1-E | Caspase-3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 44 | 0.29 | Binding ≤ 10μM |
| CASP7-1-E | Caspase-7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 87 | 0.28 | Binding ≤ 10μM |
| CASP8-1-E | Caspase-8 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 130 | 0.28 | Binding ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| CASP1_HUMAN | P29466 | Caspase-1, Human | 190 | 0.27 | Binding ≤ 1μM |
| CASP3_HUMAN | P42574 | Caspase-3, Human | 1.6 | 0.35 | Binding ≤ 1μM |
| CASP7_HUMAN | P55210 | Caspase-7, Human | 2.9 | 0.34 | Binding ≤ 1μM |
| CASP8_HUMAN | Q14790 | Caspase-8, Human | 130 | 0.28 | Binding ≤ 1μM |
| CASP1_HUMAN | P29466 | Caspase-1, Human | 190 | 0.27 | Binding ≤ 10μM |
| CASP3_HUMAN | P42574 | Caspase-3, Human | 1.6 | 0.35 | Binding ≤ 10μM |
| CASP7_HUMAN | P55210 | Caspase-7, Human | 2.9 | 0.34 | Binding ≤ 10μM |
| CASP8_HUMAN | Q14790 | Caspase-8, Human | 130 | 0.28 | Binding ≤ 10μM |
| Description | Species |
|---|---|
| Activation of caspases through apoptosome-mediated cleavage | |
| Activation of DNA fragmentation factor | |
| Activation, myristolyation of BID and translocation to mitochondria | |
| Apoptotic cleavage of cell adhesion proteins | |
| Apoptotic cleavage of cellular proteins | |
| Apoptotic execution phase | |
| Caspase-8 activation by cleavage | |
| Caspase-mediated cleavage of cytoskeletal proteins | |
| Degradation of the extracellular matrix | |
| Dimerization of procaspase-8 | |
| FasL/ CD95L signaling | |
| Interleukin-1 processing | |
| NADE modulates death signalling | |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | |
| NOD1/2 Signaling Pathway | |
| Regulation by c-FLIP | |
| Role of DCC in regulating apoptosis | |
| Signaling by Hippo | |
| SMAC binds to IAPs | |
| SMAC-mediated dissociation of IAP:caspase complexes | |
| Stimulation of the cell death response by PAK-2p34 | |
| The AIM2 inflammasome | |
| The IPAF inflammasome | |
| The NLRP3 inflammasome | |
| TRAIL signaling | |
| TRIF-mediated programmed cell death |
